Triple
T16185382
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Office of Surveillance and Epidemiology |
E392786
|
entity |
| Predicate | usesDataSource |
P11520
|
FINISHED |
| Object |
FDA Adverse Event Reporting System
The FDA Adverse Event Reporting System is a U.S. Food and Drug Administration database that collects and analyzes reports of adverse events and medication errors associated with drugs and therapeutic biologic products.
|
E1199973
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: FDA Adverse Event Reporting System | Statement: [Office of Surveillance and Epidemiology, usesDataSource, FDA Adverse Event Reporting System]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: FDA Adverse Event Reporting System Context triple: [Office of Surveillance and Epidemiology, usesDataSource, FDA Adverse Event Reporting System]
-
A.
Vaccine Adverse Event Reporting System
The Vaccine Adverse Event Reporting System (VAERS) is a U.S. national surveillance program that collects and analyzes reports of possible side effects following vaccination to monitor vaccine safety.
-
B.
FDA Risk Evaluation and Mitigation Strategies authority
The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
-
C.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
D.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
E.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: FDA Adverse Event Reporting System Triple: [Office of Surveillance and Epidemiology, usesDataSource, FDA Adverse Event Reporting System]
Generated description
The FDA Adverse Event Reporting System is a U.S. Food and Drug Administration database that collects and analyzes reports of adverse events and medication errors associated with drugs and therapeutic biologic products.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: FDA Adverse Event Reporting System Target entity description: The FDA Adverse Event Reporting System is a U.S. Food and Drug Administration database that collects and analyzes reports of adverse events and medication errors associated with drugs and therapeutic biologic products.
-
A.
Vaccine Adverse Event Reporting System
The Vaccine Adverse Event Reporting System (VAERS) is a U.S. national surveillance program that collects and analyzes reports of possible side effects following vaccination to monitor vaccine safety.
-
B.
FDA Risk Evaluation and Mitigation Strategies authority
The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
-
C.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
D.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
E.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d87f1e49ac8190a311b54d32990576 |
completed | April 10, 2026, 4:39 a.m. |
| NER | Named-entity recognition | batch_69e22060dcf88190b7c662946a5f0191 |
completed | April 17, 2026, 11:58 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ffff0550b48190ac84946b7254552b |
completed | May 10, 2026, 3:44 a.m. |
| NEDg | Description generation | batch_6a0000a8a74c8190925c4140cf4a8520 |
completed | May 10, 2026, 3:51 a.m. |
| NED2 | Entity disambiguation (via description) | batch_6a0004ceda8c8190a358f58f76116a7f |
completed | May 10, 2026, 4:08 a.m. |
Created at: April 10, 2026, 5:02 a.m.